| Literature DB >> 26216018 |
Arvind Negi1, Jimi Marin Alex1, Suyog M Amrutkar2, Ashish T Baviskar2, Gaurav Joshi1, Sandeep Singh3, Uttam C Banerjee2, Raj Kumar4.
Abstract
Microwave-accelerated synthesis and anticancer activity of novel imine/amide-imidazole conjugates derived from 5-amino-4-cyano-N1-substituted benzyl imidazole against a panel of seven cancer cell lines are reported for the first time. Compounds ARK-4, 10 and 12 in the series show promising in vitro anti proliferative activity with low micromolar IC50 values against A-459 (lung), Hep-G2 (liver) and H-460 (liver) cancer cell lines. Compounds caused the increase in ROS levels as well as mitochondrial membrane depolarization, which might induce apoptosis. Further, mechanistic interventions on biological and molecular modeling data supported that compounds inhibited topoisomerase-II selectively.Entities:
Keywords: Anticancer activity; Antioxidant activity; Imine/amide–imidazole; Molecular modeling; Topoisomerase inhibition
Mesh:
Substances:
Year: 2015 PMID: 26216018 DOI: 10.1016/j.bmc.2015.07.020
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641